Gene · 5236
Papers2,310
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 2,310
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| ARHGAP24 represses β-catenin transactivation-induced invasiveness in hepatocellular carcinoma mainly by acting as a GTPase-independent scaffold. | Theranostics | 2022 | 36168627 | PubTator, text mining | PubMed |
| Crosstalk between Glycogen-Selective Autophagy, Autophagy and Apoptosis as a Road towards Modifier Gene Discovery and New Therapeutic Strategies for Glycogen Storage Diseases. | Life (Basel) | 2022 | 36143432 | PubTator, text mining | PubMed |
| TGF-β signaling in the tumor metabolic microenvironment and targeted therapies. | J Hematol Oncol | 2022 | 36115986 | PubTator, text mining | PubMed |
| Benign fibrous histiocytoma of the medial rectus muscle. | J AAPOS | 2022 | 36113696 | PubTator, text mining | PubMed |
| The known unknowns of apolipoprotein glycosylation in health and disease. | iScience | 2022 | 36111253 | PubTator, text mining | PubMed |
| Clinical and Pathological Features of Persistent Decorative Tattoo Reactions. | Indian J Dermatol | 2022 | 36092195 | PubTator, text mining | PubMed |
| The molecular, immune features, and risk score construction of intraductal papillary mucinous neoplasm patients. | Front Mol Biosci | 2022 | 36090038 | PubTator, text mining | PubMed |
| Gene Ontology (GO)-Driven Inference of Candidate Proteomic Markers Associated with Muscle Atrophy Conditions. | Molecules | 2022 | 36080280 | PubTator, text mining | PubMed |
| The Efficacy of PD-1/PD-L1 Inhibitors in Patients with Liver Metastasis of Non-Small Cell Lung Cancer: A Real-World Study. | Cancers (Basel) | 2022 | 36077868 | PubTator, text mining | PubMed |
| NMR-based metabolomic analysis identifies RON-DEK-β-catenin dependent metabolic pathways and a gene signature that stratifies breast cancer patient survival. | PLoS One | 2022 | 36067206 | PubTator, text mining | PubMed |
| Electrospray Ionization Mass Spectrometry of Transferrin: Use of Quadrupole Mass Analyzers for Congenital Disorders of Glycosylation. | Mass Spectrom (Tokyo) | 2022 | 36060529 | PubTator, text mining | PubMed |
| The immunosuppression pathway of tumor-associated macrophages is controlled by heme oxygenase-1 in glioblastoma patients. | Int J Cancer | 2022 | 36054818 | PubTator, text mining | PubMed |
| Myeloid/lymphoid neoplasm with eosinophilia and rearrangement of PDGFRA presenting as myeloid sarcoma. | EJHaem | 2022 | 36051048 | PubTator, text mining | PubMed |
| Impact of a bisphenol A, F, and S mixture and maternal care on the brain transcriptome of rat dams and pups. | Neurotoxicology | 2022 | 36041667 | PubTator, text mining | PubMed |
| Case report: Congenital hyperinsulinemia with ABCC8 gene mutations. | Front Pediatr | 2022 | 36034573 | PubTator, text mining | PubMed |
| Multi-OMICs analysis reveals metabolic and epigenetic changes associated with macrophage polarization. | J Biol Chem | 2022 | 36030823 | PubTator, text mining | PubMed |
| Midkine expression by stem-like tumor cells drives persistence to mTOR inhibition and an immune-suppressive microenvironment. | Nat Commun | 2022 | 36028490 | PubTator, text mining | PubMed |
| Lymphoplasmacyte-rich meningioma with hematologic signs and PD-L1 over-expression. | Autops Case Rep | 2022 | 35996712 | PubTator, text mining | PubMed |
| Central nervous system involvement of systemic ALK-positive histiocytosis with KIF5B-ALK fusion. | Radiol Case Rep | 2022 | 35982724 | PubTator, text mining | PubMed |
| TFE3 and TFEB-rearranged renal cell carcinomas: an immunohistochemical panel to differentiate from common renal cell neoplasms. | Virchows Arch | 2022 | 35980471 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5236/papers?page=16